X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52172) 52172
Newsletter (2845) 2845
Publication (2596) 2596
Book Review (185) 185
Magazine Article (84) 84
Book Chapter (45) 45
Dissertation (45) 45
Conference Proceeding (44) 44
Newspaper Article (39) 39
Reference (6) 6
Book / eBook (5) 5
Web Resource (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Government Document (2) 2
Presentation (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40227) 40227
female (25972) 25972
male (21785) 21785
middle aged (21612) 21612
fluorouracil - administration & dosage (21275) 21275
oncology (20034) 20034
fluorouracil (19584) 19584
aged (18773) 18773
antineoplastic combined chemotherapy protocols - therapeutic use (16800) 16800
adult (15634) 15634
chemotherapy (13905) 13905
index medicus (13753) 13753
cancer (12340) 12340
fluorouracil - therapeutic use (10822) 10822
5-fluorouracil (8820) 8820
treatment outcome (8271) 8271
animals (7597) 7597
fluorouracil - adverse effects (6280) 6280
fluorouracil - pharmacology (6050) 6050
colorectal cancer (6016) 6016
combined modality therapy (6007) 6007
antineoplastic combined chemotherapy protocols - adverse effects (5979) 5979
colorectal neoplasms - drug therapy (5737) 5737
cisplatin - administration & dosage (5593) 5593
research (5255) 5255
care and treatment (5212) 5212
neoplasm staging (5161) 5161
leucovorin (5116) 5116
prognosis (5046) 5046
surgery (4958) 4958
aged, 80 and over (4943) 4943
breast neoplasms - drug therapy (4899) 4899
leucovorin - administration & dosage (4709) 4709
carcinoma (4671) 4671
antineoplastic combined chemotherapy protocols - administration & dosage (4525) 4525
chemotherapy, adjuvant (4525) 4525
drug administration schedule (4399) 4399
mice (4389) 4389
deoxycytidine - analogs & derivatives (4337) 4337
adenocarcinoma - drug therapy (4233) 4233
survival rate (4209) 4209
therapy (4198) 4198
capecitabine (4170) 4170
colorectal neoplasms - pathology (4156) 4156
oxaliplatin (4086) 4086
fluorouracil - analogs & derivatives (4037) 4037
disease-free survival (4021) 4021
pharmacology & pharmacy (3830) 3830
retrospective studies (3797) 3797
cisplatin (3728) 3728
survival (3727) 3727
antineoplastic agents - therapeutic use (3590) 3590
radiotherapy (3451) 3451
survival analysis (3402) 3402
follow-up studies (3294) 3294
metastasis (3225) 3225
neoplasm metastasis (3208) 3208
stomach neoplasms - drug therapy (3177) 3177
analysis (3135) 3135
liver neoplasms - secondary (3125) 3125
organoplatinum compounds - administration & dosage (3106) 3106
time factors (3072) 3072
medicine & public health (3049) 3049
antimetabolites, antineoplastic - therapeutic use (3027) 3027
liver neoplasms - drug therapy (3000) 3000
trial (2996) 2996
camptothecin - analogs & derivatives (2988) 2988
cyclophosphamide - administration & dosage (2956) 2956
colonic neoplasms - drug therapy (2836) 2836
deoxycytidine - administration & dosage (2807) 2807
antimetabolites, antineoplastic - administration & dosage (2777) 2777
carcinoma, squamous cell - drug therapy (2553) 2553
cell line, tumor (2496) 2496
irinotecan (2486) 2486
antineoplastic agents - administration & dosage (2471) 2471
prospective studies (2423) 2423
dose-response relationship, drug (2422) 2422
methotrexate - administration & dosage (2409) 2409
breast cancer (2395) 2395
drug therapy, combination (2346) 2346
doxorubicin - administration & dosage (2284) 2284
oncology, experimental (2277) 2277
health aspects (2261) 2261
breast neoplasms - pathology (2231) 2231
drug therapy (2217) 2217
tumors (2193) 2193
colorectal-cancer (2190) 2190
bevacizumab (2125) 2125
camptothecin - administration & dosage (2112) 2112
apoptosis (2071) 2071
1st-line treatment (2035) 2035
lymphatic metastasis (2034) 2034
infusions, intravenous (1994) 1994
colon cancer (1976) 1976
adenocarcinoma - pathology (1971) 1971
adenocarcinoma (1936) 1936
expression (1913) 1913
adjuvant chemotherapy (1912) 1912
antineoplastic agents - pharmacology (1905) 1905
combination (1905) 1905
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (47690) 47690
Japanese (3379) 3379
German (1077) 1077
French (968) 968
Chinese (782) 782
Russian (615) 615
Italian (137) 137
Spanish (108) 108
Polish (101) 101
Korean (78) 78
Portuguese (52) 52
Hungarian (43) 43
Danish (29) 29
Czech (28) 28
Hebrew (22) 22
Norwegian (21) 21
Swedish (13) 13
Ukrainian (13) 13
Dutch (11) 11
Romanian (11) 11
Slovak (11) 11
Bulgarian (10) 10
Croatian (6) 6
Serbian (6) 6
Finnish (5) 5
Lithuanian (5) 5
Arabic (2) 2
Turkish (2) 2
Afrikaans (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmaceutical Research, ISSN 0724-8741, 05/2015, Volume 32, Issue 5, p. 1585
We optimize the encapsulation and investigate the pharmacokinetics of 5-Fluorouracil (5-FU) delivered by thermosensitive stealth.sup.[R] liposomes (TSLs)... 
Fluorouracil
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 11/2013, Volume 69, p. 508
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 12/2013, Volume 58, Issue 12, p. 3440
Although 5-fluorouracil (5-FU) is a widely used as chemotherapy agent, severe mucositis develops in approximately 80 % of patients. 5-FU-induced small... 
Fluorouracil
Journal Article
The Journal of Supercritical Fluids, ISSN 0896-8446, 08/2013, Volume 80, p. 1
Journal Article
JDDG, ISSN 1610-0379, 05/2015, Volume 13, Issue 5, p. 430
  Zusammenfassung Hintergrund Der Anteil der in Deutschland diagnostizierten und dermatologisch behandelten aktinischen Keratosen (AK) ist in den letzten... 
Fluorouracil
Journal Article
Der Onkologe, ISSN 0947-8965, 01/2013, Volume 19, Issue 1, p. 64
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 33, pp. 5210 - 5217
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
Prescriber, ISSN 0959-6682, 05/2014, Volume 25, Issue 10, pp. 33 - 33
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2015, Volume 87, p. S72
Journal Article
Clinical cancer research, ISSN 1078-0432, 2011, Volume 17, Issue 10, pp. 3455 - 3468
To explore the effect of dihydropyrimidine dehydrogenase (DPD) single nucleotide polymorphisms (SNP) and haplotypes on outcome of capecitabine. Germline DNA... 
IVS14+1G-GREATER-THAN-A MUTATION | 1ST-LINE TREATMENT | MULTICENTER RANDOMIZED-TRIAL | POINT MUTATION | ONCOLOGY | DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY | FLUOROURACIL PLUS LEUCOVORIN | PHASE-III | SPLICE DONOR SITE | DPD DEFICIENCY | SEVERE 5-FLUOROURACIL TOXICITY | Haplotypes | Capecitabine | Colorectal Neoplasms - genetics | Humans | Middle Aged | Polymorphism, Single Nucleotide - physiology | Male | Case-Control Studies | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Clinical Trials, Phase III as Topic | Deoxycytidine - therapeutic use | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - genetics | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Retrospective Studies | Carcinoma - drug therapy | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Disease Progression | Randomized Controlled Trials as Topic | Antimetabolites, Antineoplastic - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Carcinoma - genetics | Aged | Biomarkers, Tumor - genetics | Biomarkers, Pharmacological - metabolism | Dihydrouracil Dehydrogenase (NADP) - metabolism | Deoxycytidine - analogs & derivatives | Dihydrouracil Dehydrogenase (NADP) - genetics | Cohort Studies | Index Medicus
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 02/2016, Volume 137, p. 9
* HP-[beta]-CD inclusion and thermo-reversible techniques were applied in combination. * 5FU-HP-[sz]-CD complex increased drug solubility and facilitated drug... 
Cyclodextrins | Fluorouracil
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2015, Volume 107, Issue 11, p. 1
Journal Article